
Sign up to save your podcasts
Or


Dr Jamie Chaft reviews the biological and clinical differences among MET biomarkers in NSCLC, emphasizing the importance of matching the specific biomarker question to the appropriate assay. The discussion covers NGS, IHC, and FISH, as well as specimen availability, prior therapy exposure, and the evolving clinical context.
By HMP GlobalDr Jamie Chaft reviews the biological and clinical differences among MET biomarkers in NSCLC, emphasizing the importance of matching the specific biomarker question to the appropriate assay. The discussion covers NGS, IHC, and FISH, as well as specimen availability, prior therapy exposure, and the evolving clinical context.